| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
13,870,000 |
| Market
Cap: |
450.08(M) |
| Last
Volume: |
50,046 |
Avg
Vol: |
64,913 |
| 52
Week Range: |
$17.67 - $38.49 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
9,872 |
| Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Arens Timothy J. |
Interim VP, Finance, and CFO |
• – – |
2018-11-27 |
4 |
D |
$56.63 |
$224,991 |
D/D |
(3,973) |
46,245 |
|
- |
|
| Arens Timothy J. |
Interim VP, Finance, and CFO |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,006 |
50,218 |
|
- |
|
| Sutton Gregg S |
VP of Research and Development |
• – – |
2018-11-27 |
4 |
D |
$56.63 |
$234,561 |
D/D |
(4,142) |
17,503 |
|
- |
|
| Sutton Gregg S |
VP of Research and Development |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,731 |
21,645 |
|
- |
|
| Maharaj Gary R |
President & CEO |
• • – |
2018-11-27 |
4 |
D |
$56.63 |
$613,529 |
D/D |
(10,834) |
187,915 |
|
- |
|
| Maharaj Gary R |
President & CEO |
• • – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
33,470 |
198,749 |
|
- |
|
| Olson Charles W |
Senior VP of Bus Dev, Med Dev |
• – – |
2018-11-27 |
4 |
D |
$56.63 |
$224,991 |
D/D |
(3,973) |
36,358 |
|
- |
|
| Olson Charles W |
Senior VP of Bus Dev, Med Dev |
• – – |
2018-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,006 |
40,331 |
|
- |
|
| Stich Joseph J. |
VP and GM, IVD |
• – – |
2018-11-09 |
4 |
AS |
$62.07 |
$127,543 |
D/D |
(2,000) |
50,208 |
|
- |
|
| Maharaj Gary R |
President & CEO |
• • – |
2018-10-01 |
4 |
AS |
$72.04 |
$361,773 |
D/D |
(5,000) |
169,867 |
|
- |
|
| Kalich Ronald B Sr |
Director |
– • – |
2018-09-28 |
4 |
A |
$74.65 |
$15,229 |
D/D |
204 |
12,421 |
|
- |
|
| Mccormick Shawn |
Director |
– • – |
2018-09-28 |
4 |
A |
$74.65 |
$6,271 |
D/D |
84 |
6,766 |
|
- |
|
| Dantzker David |
Director |
– • – |
2018-09-28 |
4 |
A |
$74.65 |
$13,960 |
D/D |
187 |
19,846 |
|
- |
|
| Olson Charles W |
Senior VP of Bus Dev, Med Dev |
• – – |
2018-09-26 |
4 |
D |
$73.60 |
$81,622 |
D/D |
(1,109) |
29,325 |
|
- |
|
| Arens Timothy J. |
Interim VP, Finance, and CFO |
• – – |
2018-09-26 |
4 |
D |
$73.60 |
$45,632 |
D/D |
(620) |
39,212 |
|
- |
|
| Maharaj Gary R |
President & CEO |
• • – |
2018-09-04 |
4 |
AS |
$79.40 |
$397,996 |
D/D |
(5,000) |
170,279 |
|
- |
|
| Phillips Bryan K |
SVP, Gen Counsel & Secretary |
• – – |
2018-08-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
26,587 |
|
- |
|
| Knight Susan E |
Director |
– • – |
2018-08-28 |
4 |
D |
$74.85 |
$152,844 |
D/D |
(2,042) |
24,798 |
|
- |
|
| Knight Susan E |
Director |
– • – |
2018-08-28 |
4 |
OE |
$20.37 |
$152,772 |
D/D |
7,112 |
26,840 |
|
- |
|
| Heine Lisa Wipperman |
Director |
– • – |
2018-08-24 |
4 |
D |
$74.15 |
$168,469 |
D/D |
(2,272) |
7,482 |
|
- |
|
| Heine Lisa Wipperman |
Director |
– • – |
2018-08-24 |
4 |
OE |
$23.50 |
$168,380 |
D/D |
6,739 |
9,754 |
|
- |
|
| Sutton Gregg S |
VP of Research and Development |
• – – |
2018-08-23 |
4 |
S |
$74.11 |
$1,099,093 |
D/D |
(14,824) |
9,309 |
|
- |
|
| Sutton Gregg S |
VP of Research and Development |
• – – |
2018-08-23 |
4 |
OE |
$19.42 |
$307,270 |
D/D |
14,824 |
24,133 |
|
- |
|
| Knight Susan E |
Director |
– • – |
2018-08-16 |
4 |
S |
$72.93 |
$437,580 |
D/D |
(6,000) |
19,728 |
|
- |
|
| Stich Joseph J. |
VP and GM, IVD |
• – – |
2018-08-10 |
4 |
AS |
$67.30 |
$139,516 |
D/D |
(2,000) |
51,919 |
|
- |
|
888 Records found
|
|
Page 13 of 36 |
|
|
0.29 (0.9%) 
